Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of the Interi Manifold in Implant-Based Breast Reconstruction

NCT: NCT05975359 · RECRUITING

NCT IDNCT05975359
StatusRECRUITING
Start Date2023-10-05
Completion2026-09

Brief Summary

Patients with breast cancer that elect to undergo implant-based breast reconstruction (IBBR) often require the placement of a surgical drain. Surgical drains are used to manage dead space and prevent seroma formation or accumulation of fluid within the surgical field postoperatively. The most frequently used drain is a Jackson-Pratt (JP) drain, which is limited by poor surgical site coverage and low capacity, leading to inconsistent suction and prolonged time that a drain is left in place. The Interi Drain system is a novel, multi-branched manifold with a proprietary suction system that provides consistent suction and addresses many of the shortcoming of JP drains. The purpose of this study is to compare the Interi system to standard JP drains across outcomes including number of surgical drain sites, complication rates, time to drain removal, time to initiate tissue expansion, total fluid volume drained, and patient satisfaction.

Frequently Asked Questions

What is Assessment of the Interi Manifold in Implant-Based Breast Reconstruction?

Assessment of the Interi Manifold in Implant-Based Breast Reconstruction is a clinical trial registered under NCT05975359. Current status: RECRUITING.

What is the status of NCT05975359?

The current status of NCT05975359 (Assessment of the Interi Manifold in Implant-Based Breast Reconstruction) is: RECRUITING.

When did Assessment of the Interi Manifold in Implant-Based Breast Reconstruction start?

Assessment of the Interi Manifold in Implant-Based Breast Reconstruction started on 2023-10-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.